DE69328962T2 - Verfahren zur herstellng von cyano-methoxyiminomethylderivaten - Google Patents

Verfahren zur herstellng von cyano-methoxyiminomethylderivaten

Info

Publication number
DE69328962T2
DE69328962T2 DE69328962T DE69328962T DE69328962T2 DE 69328962 T2 DE69328962 T2 DE 69328962T2 DE 69328962 T DE69328962 T DE 69328962T DE 69328962 T DE69328962 T DE 69328962T DE 69328962 T2 DE69328962 T2 DE 69328962T2
Authority
DE
Germany
Prior art keywords
methoxyiminomethyl
derivatives
producing cyano
cyano
producing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69328962T
Other languages
English (en)
Other versions
DE69328962D1 (de
Inventor
Mark Jason Hughes
John Kitteringham
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Ltd
Original Assignee
SmithKline Beecham Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Ltd filed Critical SmithKline Beecham Ltd
Publication of DE69328962D1 publication Critical patent/DE69328962D1/de
Application granted granted Critical
Publication of DE69328962T2 publication Critical patent/DE69328962T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/08—Bridged systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Catalysts (AREA)
  • Saccharide Compounds (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE69328962T 1992-02-20 1993-02-11 Verfahren zur herstellng von cyano-methoxyiminomethylderivaten Expired - Fee Related DE69328962T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB929203688A GB9203688D0 (en) 1992-02-20 1992-02-20 Novel process
PCT/GB1993/000291 WO1993017018A1 (en) 1992-02-20 1993-02-11 Nitrosation process

Publications (2)

Publication Number Publication Date
DE69328962D1 DE69328962D1 (de) 2000-08-10
DE69328962T2 true DE69328962T2 (de) 2000-12-28

Family

ID=10710781

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69328962T Expired - Fee Related DE69328962T2 (de) 1992-02-20 1993-02-11 Verfahren zur herstellng von cyano-methoxyiminomethylderivaten

Country Status (19)

Country Link
US (2) US5545740A (de)
EP (2) EP0984008A3 (de)
JP (1) JP3288704B2 (de)
KR (1) KR100261530B1 (de)
AT (1) ATE194341T1 (de)
AU (1) AU669355B2 (de)
CA (1) CA2131019C (de)
DE (1) DE69328962T2 (de)
DK (1) DK0626961T3 (de)
ES (1) ES2147749T3 (de)
GB (1) GB9203688D0 (de)
GR (1) GR3034295T3 (de)
HK (1) HK1012366A1 (de)
MX (1) MX9300875A (de)
NZ (1) NZ246940A (de)
PT (1) PT626961E (de)
TW (1) TW224466B (de)
WO (1) WO1993017018A1 (de)
ZA (1) ZA931132B (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX9300875A (es) 1992-02-20 1993-08-31 Smithkline Beecham Plc Procedimiento para la preparacion de compuestos azabiciclicos.
GB9409705D0 (en) * 1994-05-14 1994-07-06 Smithkline Beecham Plc Novel compounds
GB9421472D0 (en) * 1994-10-25 1994-12-07 Smithkline Beecham Plc Novel methods
GB9615628D0 (en) * 1996-07-25 1996-09-04 Smithkline Beecham Plc Formulation
EP1007041A4 (de) * 1997-04-11 2001-03-07 Lilly Co Eli Zusammensetzung zur behandlung von schmerzen
EP1009403A4 (de) * 1997-04-11 2002-08-28 Lilly Co Eli Verfahren zur behandlung von schizophrenie
CA2620333A1 (en) * 2005-08-26 2007-03-01 Braincells, Inc. Neurogenesis by muscarinic receptor modulation
EP2258359A3 (de) 2005-08-26 2011-04-06 Braincells, Inc. Neurogenese durch Modulation des Muscarinrezeptors mit Sabcomelin
EP2377530A3 (de) 2005-10-21 2012-06-20 Braincells, Inc. Modulation von Neurogenese durch PDE-Hemmung
WO2007053596A1 (en) 2005-10-31 2007-05-10 Braincells, Inc. Gaba receptor mediated modulation of neurogenesis
US20100216734A1 (en) 2006-03-08 2010-08-26 Braincells, Inc. Modulation of neurogenesis by nootropic agents
JP2009536669A (ja) 2006-05-09 2009-10-15 ブレインセルス，インコーポレイティド アンジオテンシン調節による神経新生
EP2026813A2 (de) 2006-05-09 2009-02-25 Braincells, Inc. 5-ht-rezeptor-vermittelte neurogenese
KR20090064418A (ko) 2006-09-08 2009-06-18 브레인셀즈 인코퍼레이션 4-아실아미노피리딘 유도체 포함 조합물
US20100184806A1 (en) 2006-09-19 2010-07-22 Braincells, Inc. Modulation of neurogenesis by ppar agents
US20100216805A1 (en) 2009-02-25 2010-08-26 Braincells, Inc. Modulation of neurogenesis using d-cycloserine combinations

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1600969A (en) 1977-01-07 1981-10-21 Acf Chemiefarma Nv Heterocyclic compounds
US4937239A (en) * 1989-02-13 1990-06-26 Warner-Lambert Company Azabicycloalkane oxime & azabicycloalkene oxime muscarinic agents
ES2219636T3 (es) * 1989-04-13 2004-12-01 Beecham Group P.L.C. Nuevos compuestos.
US5418240A (en) 1990-08-21 1995-05-23 Novo Nordisk A/S Heterocyclic compounds and their preparation and use
DK198590D0 (da) * 1990-08-21 1990-08-21 Novo Nordisk As Heterocykliske forbindelser, deres fremstilling og anvendelse
MX9300875A (es) 1992-02-20 1993-08-31 Smithkline Beecham Plc Procedimiento para la preparacion de compuestos azabiciclicos.

Also Published As

Publication number Publication date
ES2147749T3 (es) 2000-10-01
KR950700292A (ko) 1995-01-16
DK0626961T3 (da) 2000-11-06
DE69328962D1 (de) 2000-08-10
NZ246940A (en) 1996-06-25
US6596869B2 (en) 2003-07-22
AU669355B2 (en) 1996-06-06
CA2131019C (en) 2002-12-24
US5545740A (en) 1996-08-13
MX9300875A (es) 1993-08-31
PT626961E (pt) 2000-10-31
ATE194341T1 (de) 2000-07-15
EP0626961A1 (de) 1994-12-07
GR3034295T3 (en) 2000-12-29
GB9203688D0 (en) 1992-04-08
EP0626961B1 (de) 2000-07-05
TW224466B (de) 1994-06-01
JPH07504180A (ja) 1995-05-11
AU3460793A (en) 1993-09-13
WO1993017018A1 (en) 1993-09-02
JP3288704B2 (ja) 2002-06-04
US20020143185A1 (en) 2002-10-03
ZA931132B (en) 1993-10-14
KR100261530B1 (ko) 2000-08-01
HK1012366A1 (en) 1999-07-30
EP0984008A3 (de) 2000-05-03
CA2131019A1 (en) 1993-08-21
EP0984008A2 (de) 2000-03-08

Similar Documents

Publication Publication Date Title
DE69328962T2 (de) Verfahren zur herstellng von cyano-methoxyiminomethylderivaten
ATE154016T1 (de) Verfahren zur herstellung von chlorothiazolderivaten
ATE145891T1 (de) Verfahren zur herstellung von alkoxyiminoacetamid-derivaten und ein zwischenproduckt dafür
DE69322708D1 (de) Neues Verfahren zur Herstellung von 7-(substituierten)-9-[(substistuierter Glycyl)amido]-6-demethyl-6-deoxytetracyclinen
DE3775882D1 (de) Substituierte 6-fluor-4-oxo-1,4-dihydrochinolin-3-carbonsaeuren ; deren derivate; diese verbindung enthaltende pharmazeutische zubereitungen und verfahren zur herstellung dieser verbindungen.
ATE158798T1 (de) Verfahren zur herstellung von optisch aktiven zyklobutannukleosiden
DE58909125D1 (de) Verfahren zur Herstellung von Diorganodialkoxysilanen.
ATE127809T1 (de) Verfahren zur herstellung von verbindungen zur behandlung der gutartigen prostatahypertrophie.
ATE167677T1 (de) Verfahren zur reinigung von roher clavulansäure
ATE121404T1 (de) Verfahren zur optischen aufspaltung von pyranobenzoxadiazolverbindungen.
DE69507887D1 (de) Verfahren zur herstellung von n-biphenylmethylthiadiazolin derivaten oder deren salzen sowie dafür benötigte zwischen verbindungen
ATE172734T1 (de) Verfahren zur herstellung von ceftriaxon
ATE353937T1 (de) Verfahren zur synthese einer oxonolverbindung
ATE135369T1 (de) Chemisches verfahren zur herstellung des antibiotikums l 17392 (deglukoteicoplanin) und dessen salze
ATE139999T1 (de) Verfahren zur herstellung von fluormethyl- substituierter piperidin-carbodithioaten
ATE215931T1 (de) Verfahren zur herstellung von 2- oxopyrrolidinylacetamid-derivaten
ATE63107T1 (de) Verfahren zur synthese von carbonsaeuren.
ATE155132T1 (de) Verfahren zur herstellung von amino- thiadiazolylacetylhaliden
DE3777537D1 (de) Neues verfahren zur herstellung von cephalosporinderivaten.
ATE179417T1 (de) Glyceraldehyd-3-pentanid und verfahren zu ihrer herstellung
ATE177737T1 (de) Verfahren zur herstellung von 5-arylhydantoin
ATE206109T1 (de) Verfahren zur herstellung von carbamoylmethylharnstoff-derivaten
DE69520554T2 (de) Verfahren zur herstellung von indolocarbazol-derivaten
ATE162522T1 (de) Verfahren zur herstellung von heterocyclischen derivaten
ATE92481T1 (de) Verfahren zur herstellung von n,n'-bis-(2hydroxyethyl)-piperazin.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee